LXFR
Luxfer Holdings PLC [LXFR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
LXFR Stock Summary
Top LXFR Correlated Resources
LXFR
Top 10 Correlated ETFs
LXFR
Top 10 Correlated Stocks
LXFR
In the News
Luxfer Holdings PLC (LXFR) Q3 2022 Earnings Call Transcript
Luxfer Holdings PLC (NYSE:LXFR ) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants Michael Gaiden - VP, IR and Business Development Andy Butcher - CEO Steve Webster - CFO Conference Call Participants Chris Moore - CJS Securities Phil Gibbs - KeyBanc Capital Markets Chip Moore - EF Hutton Presentation Operator Good morning, my name is Katie and I'll be your conference operator today. Welcome to the Luxfer's Third Quarter 2022 Earnings Conference Call.
5 Stocks to Watch on Recent Dividend Hikes as Rates Rise
Investors may keep a tab on LXFR, OZK, FLIC, LMT and HON, which have lately hiked their dividend payments to generate regular income.
Luxfer Declares Quarterly Dividend and Announces Date of Third Quarter Earnings Release
MILWAUKEE, Wis.--(BUSINESS WIRE)--Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced that its Board of Directors has declared a quarterly dividend of 13 cents per ordinary share. The dividend will be payable on November 2, 2022 to shareholders of record as of the close of business on October 14, 2022. All holders of NYSE-listed ordinary shares will be paid in U.S. dollars through the C
Luxfer Holdings PLC (LXFR) CEO Andy Butcher on Q2 2022 Results - Earnings Call Transcript
Luxfer Holdings PLC (NYSE:LXFR ) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants Michael Gaiden - VP, IR and Business Development Andy Butcher – CEO Steve Webster – CFO Conference Call Participants Chris Moore – CJS Securities Phil Gibbs – KeyBanc Capital Chip Moore – EF Hutton Operator Good morning. My name is Katie and I will be your conference operator today.
Luxfer (LXFR) Beats Q2 Earnings and Revenue Estimates
Luxfer (LXFR) delivered earnings and revenue surprises of 5.88% and 4.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Luxfer (LXFR) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Luxfer (LXFR) have what it takes?
Luxfer Declares Quarterly Dividend and Announces Date of Second Quarter Earnings Release
MILWAUKEE--(BUSINESS WIRE)--Luxfer Declares Quarterly Dividend and Announces Date of Second Quarter Earnings Release
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Luxfer (LXFR) have what it takes?
LXFR vs. NDSN: Which Stock Should Value Investors Buy Now?
LXFR vs. NDSN: Which Stock Is the Better Value Option?
Why Luxfer (LXFR) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Luxfer (LXFR) have what it takes?
LXFR Financial details
LXFR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 16.68 | 18.27 | 16.25 | 11.79 | 13.49 | |
| Net income per share | 0.43 | 0.94 | 0.11 | 0.73 | 1.08 | |
| Operating cash flow per share | 1.71 | 2.37 | 0.21 | 1.8 | 0.94 | |
| Free cash flow per share | 1.28 | 1.85 | -0.3 | 1.51 | 0.61 | |
| Cash per share | 0.56 | 0.52 | 0.37 | 0.05 | 0.22 | |
| Book value per share | 6.13 | 6.9 | 6.39 | 6.06 | 7.54 | |
| Tangible book value per share | 3.05 | 3.82 | 3.37 | 3.05 | 4.53 | |
| Share holders equity per share | 6.13 | 6.9 | 6.39 | 6.06 | 7.54 | |
| Interest debt per share | 4.51 | 3.07 | 4.07 | 2.47 | 2.72 | |
| Market cap | 386.86M | 533.37M | 461.18M | 453.87M | 448M | |
| Enterprise value | 486.56M | 596.67M | 557.38M | 515.37M | 514.2M | |
| P/E ratio | 33.64 | 21.33 | 148.77 | 22.69 | 14.98 | |
| Price to sales ratio | 0.88 | 1.09 | 1.04 | 1.4 | 1.2 | |
| POCF ratio | 8.56 | 8.44 | 79.51 | 9.15 | 17.16 | |
| PFCF ratio | 11.41 | 10.82 | -56.94 | 10.91 | 26.35 | |
| P/B Ratio | 2.38 | 2.89 | 2.64 | 2.72 | 2.14 | |
| PTB ratio | 2.38 | 2.89 | 2.64 | 2.72 | 2.14 | |
| EV to sales | 1.1 | 1.22 | 1.26 | 1.59 | 1.37 | |
| Enterprise value over EBITDA | 13.08 | 10.95 | 18.7 | 11.4 | 9.52 | |
| EV to operating cash flow | 10.76 | 9.44 | 96.1 | 10.39 | 19.7 | |
| EV to free cash flow | 14.35 | 12.1 | -68.81 | 12.39 | 30.25 | |
| Earnings yield | 0.03 | 0.05 | 0.01 | 0.04 | 0.07 | |
| Free cash flow yield | 0.09 | 0.09 | -0.02 | 0.09 | 0.04 | |
| Debt to equity | 0.58 | 0.4 | 0.59 | 0.36 | 0.33 | |
| Debt to assets | 0.6 | 0.53 | 0.55 | 0.52 | 0.43 | |
| Net debt to EBITDA | 2.68 | 1.16 | 3.23 | 1.36 | 1.23 | |
| Current ratio | 2.03 | 2.06 | 2.38 | 2.31 | 1.95 | |
| Interest coverage | 3.06 | 6 | 2.64 | 5.7 | 11.68 | |
| Income quality | 3.93 | 2.53 | 1.87 | 2.48 | 0.87 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Payout ratio | 1.16 | 0.54 | 4.39 | 0.68 | 0.45 | |
| Sales general and administrative to revenue | 0.13 | 0.12 | 0.12 | 0 | 0 | |
| Research and developement to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.2 | 0.21 | 0.21 | 0.24 | 0.23 | |
| Capex to operating cash flow | -0.25 | -0.22 | -2.4 | -0.16 | -0.35 | |
| Capex to revenue | -0.03 | -0.03 | -0.03 | -0.02 | -0.02 | |
| Capex to depreciation | -0.59 | -0.73 | -0.91 | -0.6 | -0.58 | |
| Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 7.74 | 12.06 | 4.04 | 9.95 | 13.53 | |
| ROIC | 0.06 | 0.1 | 0.04 | 0.1 | 0.13 | |
| Return on tangible assets | 0.04 | 0.08 | 0.01 | 0.08 | 0.1 | |
| Graham Net | -4.92 | -3.69 | -3.96 | -4.15 | -2.6 | |
| Working capital | 86.9M | 93.4M | 102.1M | 85.5M | 79.3M | |
| Tangible asset value | 80.6M | 102.1M | 92M | 84.1M | 125.7M | |
| Net current asset value | -69M | -25M | -39.8M | -28.4M | 3.5M | |
| Invested capital | 0.7 | 0.42 | 0.61 | 0.38 | 0.35 | |
| Average receivables | 55.4M | 50.65M | 52.9M | 38.7M | 43.45M | |
| Average payables | 23.5M | 27.75M | 27.5M | 18.6M | 25.15M | |
| Average inventory | 75.5M | 81.2M | 81.65M | 68.8M | 79.65M | |
| Days sales outstanding | 59.63 | 46.83 | 55.22 | 43.49 | 47.03 | |
| Days payables outstanding | 31.16 | 36.82 | 39.6 | 27.84 | 41.61 | |
| Days of inventory on hand | 90.18 | 93.4 | 102.81 | 102.96 | 118.78 | |
| Receivables turnover | 6.12 | 7.79 | 6.61 | 8.39 | 7.76 | |
| Payables turnover | 11.71 | 9.91 | 9.22 | 13.11 | 8.77 | |
| Inventory turnover | 4.05 | 3.91 | 3.55 | 3.55 | 3.07 | |
| ROE | 0.07 | 0.14 | 0.02 | 0.12 | 0.14 | |
| Capex per share | -0.43 | -0.52 | -0.51 | -0.29 | -0.33 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-25 for Q3
| Metric | History | 2021-09-26 | 2021-12-31 | 2022-03-27 | 2022-06-26 | 2022-09-25 |
|---|---|---|---|---|---|---|
| Revenue per share | 3.28 | 3.57 | 3.53 | 3.99 | 3.67 | |
| Net income per share | 0.22 | -0.01 | 0.28 | 0.34 | 0.29 | |
| Operating cash flow per share | 0.35 | -0.29 | -0.34 | 0.09 | 0.13 | |
| Free cash flow per share | 0.28 | -0.42 | -0.37 | 0.02 | 0.05 | |
| Cash per share | 0.54 | 0.22 | 0.63 | 0.19 | 0.41 | |
| Book value per share | 6.72 | 7.56 | 7.52 | 7.49 | 7.15 | |
| Tangible book value per share | 3.66 | 4.55 | 4.52 | 4.6 | 4.41 | |
| Share holders equity per share | 6.72 | 7.56 | 7.52 | 7.49 | 7.15 | |
| Interest debt per share | 1.81 | 2.64 | 3.94 | 3.56 | 4.07 | |
| Market cap | 563.22M | 533.81M | 474.49M | 420.21M | 391.97M | |
| Enterprise value | 597.72M | 600.01M | 564.89M | 511.61M | 490.87M | |
| P/E ratio | 23.47 | -333.63 | 15.61 | 11.3 | 12.25 | |
| Price to sales ratio | 6.18 | 5.41 | 4.89 | 3.84 | 3.91 | |
| POCF ratio | 58.06 | -66.73 | -51.02 | 168.08 | 108.88 | |
| PFCF ratio | 73.14 | -46.42 | -46.07 | 700.34 | 301.51 | |
| P/B Ratio | 3.02 | 2.55 | 2.3 | 2.04 | 2.01 | |
| PTB ratio | 3.02 | 2.55 | 2.3 | 2.04 | 2.01 | |
| EV to sales | 6.55 | 6.08 | 5.82 | 4.67 | 4.9 | |
| Enterprise value over EBITDA | 47.82 | 92.31 | 38.69 | 31.98 | 33.62 | |
| EV to operating cash flow | 61.62 | -75 | -60.74 | 204.64 | 136.35 | |
| EV to free cash flow | 77.63 | -52.17 | -54.84 | 852.68 | 377.59 | |
| Earnings yield | 0.01 | 0 | 0.02 | 0.02 | 0.02 | |
| Free cash flow yield | 0.01 | -0.02 | -0.02 | 0 | 0 | |
| Debt to equity | 0.27 | 0.33 | 0.5 | 0.45 | 0.41 | |
| Debt to assets | 0.5 | 0.43 | 0.5 | 0.48 | 0.5 | |
| Net debt to EBITDA | 2.76 | 10.18 | 6.19 | 5.71 | 6.77 | |
| Current ratio | 2.11 | 1.95 | 2.08 | 2.08 | 1.79 | |
| Interest coverage | 10.13 | 7.86 | 13.25 | 14 | 11.6 | |
| Income quality | 1.62 | 20 | -1.22 | 0.27 | 0.45 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.57 | -8.5 | 0.45 | 0.39 | 0.45 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.23 | 0.23 | 0.2 | 0.2 | 0.19 | |
| Capex to operating cash flow | -0.21 | 0.44 | 0.11 | -0.76 | -0.64 | |
| Capex to revenue | -0.02 | -0.04 | -0.01 | -0.02 | -0.02 | |
| Capex to depreciation | -0.53 | -0.8 | -0.27 | -0.56 | -0.7 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Graham number | 5.72 | 1.57 | 6.84 | 7.56 | 6.87 | |
| ROIC | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | |
| Return on tangible assets | 0.02 | 0 | 0.02 | 0.03 | 0.03 | |
| Graham Net | -3.02 | -2.61 | -3.29 | -2.97 | -3.18 | |
| Working capital | 87.6M | 79.3M | 106.8M | 101.1M | 87.5M | |
| Tangible asset value | 101.6M | 125.7M | 124.3M | 126.2M | 120.4M | |
| Net current asset value | -17M | 3.5M | -2.5M | 3.7M | 1.2M | |
| Invested capital | 0.27 | 0.35 | 0.52 | 0.47 | 0.56 | |
| Average receivables | 58.45M | 53.05M | 60.55M | 63.25M | 57.9M | |
| Average payables | 29.3M | 29.8M | 32.85M | 30.95M | 27.9M | |
| Average inventory | 96.1M | 101.05M | 108.75M | 108.15M | 111.6M | |
| Days sales outstanding | 58.22 | 43.95 | 58.64 | 56.38 | 52.01 | |
| Days payables outstanding | 39.42 | 38.09 | 46.73 | 36.52 | 32.61 | |
| Days of inventory on hand | 103.48 | 108.74 | 130.92 | 112.45 | 130.44 | |
| Receivables turnover | 1.55 | 2.05 | 1.53 | 1.6 | 1.73 | |
| Payables turnover | 2.28 | 2.36 | 1.93 | 2.46 | 2.76 | |
| Inventory turnover | 0.87 | 0.83 | 0.69 | 0.8 | 0.69 | |
| ROE | 0.03 | 0 | 0.04 | 0.05 | 0.04 | |
| Capex per share | -0.07 | -0.13 | -0.04 | -0.07 | -0.08 |
LXFR Frequently Asked Questions
What is Luxfer Holdings PLC stock symbol ?
Luxfer Holdings PLC is a GB stock , located in Salford of Durham and trading under the symbol LXFR
What is Luxfer Holdings PLC stock quote today ?
Luxfer Holdings PLC stock price is $14.73 today.
Is Luxfer Holdings PLC stock public?
Yes, Luxfer Holdings PLC is a publicly traded company.
Company Profile
- Volume Average 66.84K
- Market Capitalization 400.78M
- Employee 1.3K
- CEO Mr. Alok Maskara
- Headquarters Salford,DURHAM,GB
- IPO Date 2012-10-03
-
Website
https://www.luxfer.com 
Luxfer Holdings PLC, together with its subsidiaries, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas containment devices for defense and emergency response, healthcare, transportation, and general industrial end-market applications. It operates in two segments, Elektron and Gas Cylinders. The Elektron segment focuses on specialty materials based on magnesium and zirconium. It provides magnesium alloys for use in variety of industries; magnesium powders for use in countermeasure flares, as well as heater meals; photoengraving plates for graphic arts; and zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and other performance products. The Gas Cylinders segment manufactures and markets specialized products using carbon composites and aluminum, including pressurized cylinders for use in various applications comprising self-contained breathing apparatus (SCBA) for firefighters, containment of oxygen, and other medical gases for healthcare, alternative fuel vehicles, and general industrial. Luxfer Holdings PLC has operations in the United States, the United Kingdom, Germany, Italy, France, rest of Europe, the Asia Pacific, and internationally. The company was founded in 1898 and is based in Manchester, the United Kingdom.
